Hypercobalaminaemia is associated with hepatic and neoplastic disease in cats: a cross sectional study

BMC Veterinary Research

Daniel J Batchelor¹  Goncalo Serrano¹  Paolo Silvestrini¹  Alexander J German²  Mary R Trehy¹ 

[1] School of Veterinary Science, University of Liverpool, Leahurst Campus, Chester High Road, Neston CH64 7TE, UK;Department of Obesity and Endocrinology, University of Liverpool, Leahurst Campus, Chester High Road, Neston CH64 7TE, UK

关键词: Feline;    Vitamin;    B12;   

Others  :  1119097
DOI  :  10.1186/s12917-014-0175-x

 received in 2014-03-04, accepted in 2014-07-22,  发布年份 2014

【 摘 要 】

Background

When increased serum cobalamin concentrations are encountered clinically they are usually attributed to parenteral supplementation, dietary factors, or otherwise ignored. However, recently, hypercobalaminaemia has been associated with numerous diseases in humans, most notably neoplastic and hepatic disorders. The aim of this retrospective, observational, cross-sectional study was to determine the significance of increased cobalamin in cats.

Results

In total, 237 records were retrieved and 174 cats, of various ages and sexes met the inclusion criteria. A total of 42 cats had increased serum cobalamin concentration, and had not received prior supplementation. Multiple logistic regression analysis revealed that increased serum cobalamin concentration was positively related to pedigree breed (pedigree breeds more likely to have increased cobalamin concentration, odds ratio [OR] 4.24, 95% CI 1.78-10.15, P = 0.001), to having liver disease (OR 9.91, 95% CI 3.54-27.68), and to having a solid neoplasm (OR 8.54, 95% CI 1.10-66.45).

Conclusions

The results of the current study suggest that increased serum cobalamin concentrations should not be ignored in cats with no history of supplementation, and investigation for underlying hepatic or neoplastic disease is warranted.

【 授权许可】

   
2014 Trehy et al.; licensee BioMed Central Ltd

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Vaden SL, Wood PA, Ledley FD, Cornwell PE, Miller RT, Page R: Cobalamin deficiency associated with methylmalonic acidemia in a cat. J Am Vet Med Assoc 1992, 200:1101-1103.
• [2]Simpson K, Battersby I, Lowrie M: Suspected acquired hypocobalaminaemic encephalopathy in a cat: resolution of encephalopathic signs and MRI lesions subsequent to cobalamin supplementation. J Feline Med Surg 2012, 14:350-355.
• [3]Maunder CL, Day MJ, Hibbert A, Steiner JM, Suchodolski JS, Hall EJ: Serum cobalamin concentrations in cats with gastrointestinal signs: correlation with histopathological findings and duration of clinical signs. J Feline Med Surg 2012, 14:686-693.
• [4]Simpson KW, Fyfe J, Cornetta A, Sachs A, Strauss-Ayali D, Lamb SV, Reimers TJ: Subnormal concentrations of serum cobalamin (vitamin B12) in cats with gastrointestinal disease. J Vet Intern Med 2001, 15:26-32.
• [5]Thompson KA, Parnell NK, Hohenhaus AE, Moore GE, Rondeau MP: Feline exocrine pancreatic insufficiency: 16 cases (1992–2007). J Feline Med Surg 2009, 11:935-940.
• [6]Cook AK, Suchodolski JS, Steiner JM, Robertson JE: The prevalence of hypocobalaminaemia in cats with spontaneous hyperthyroidism. J Small Anim Pract 2011, 52:101-106.
• [7]Ruaux CG: Cobalamin in companion animals: diagnostic marker, deficiency states and therapeutic implications. Vet J 2013, 196:145-152.
• [8]Kiselow MA, Rassnick KM, McDonough SP, Goldstein RE, Simpson KW, Weinkle TK, Erb HN: Outcome of cats with low-grade lymphocytic lymphoma: 41 cases (1995–2005). J Am Vet Med Assoc 2008, 232:405-410.
• [9]Arendt JF, Nexo E: Cobalamin related parameters and disease patterns in patients with increased serum cobalamin levels. PLoS One 2012, 7:e45979.
• [10]Beard MF, Pitney WR, Sanneman EH: Serum concentrations of vitamin B12 in patients suffering from leukemia. Blood 1954, 9:789-794.
• [11]Rachmilewitz M, Izak G, Hochman A, Aronovitch J, Grossowicz N: Serum vitamin B12 in leukemias and malignant lymphomas. Blood 1957, 12:804-813.
• [12]Hoogstraten B, Baker H, Gilbert HS: Serum folate and serum vitamin B12 in patients with malignant hematological diseases. Cancer Res 1965, 25:1933-1938.
• [13]Ryg J, Nybo M, Hallas J: Cancer incidence in persons with elevated cobalamin levels. Eur J Clin Invest 2013, 43:557-561.
• [14]Chiche L, Jean R, Romain F, Roux F, Thomas G, Canavese S, Branger S, Harlé JR, Durand JM: Clinical implications of high cobalamin blood levels for internal medicine. Rev Med Intern 2008, 29:187-194.
• [15]Andrès E, Serraj K, Zhu J, Vermorken AJ: The pathophysiology of elevated vitamin B12 in clinical practice. QJM 2013, 106:505-515.
• [16]Carmel R, Vasireddy H, Aurangzeb I, George K: High serum cobalamin levels in the clinical setting-clinical associations and holo-transcobalamin changes. Clin Lab Haematol 2001, 23:365-371.
• [17]Jammal M, Deneuville T, Mario N, Tiev K, Tolédano C, Josselin-Mahr L, Pateron D, Guidet B, Retbi A, Taright N, Cabane J, Kettaneh A: High plasmatic concentration of vitamin B12: an indicator of hepatic diseases or tumors. Rev Med Intern 2013, 34:337-341.
• [18]Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. PLoS Med 2007, 4:e26.
• [19]Arendt JF, Pedersen L, Nexo E, Sørensen HT: Elevated plasma vitamin B12 levels as a marker for cancer: a population-based cohort study. J Natl Cancer Inst 2013, 105:1799-1805.
• [20]Solomon LR: Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment. Blood Rev 2007, 21:113-130.
• [21]Ermens AA, Vlasveld LT, Lindemans J: Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem 2003, 36:585-590.
• [22]Fry JK, Burney DP, Lidbury JA, Steiner JM, Suchodolski JS, Hottinger HA, Hunter SL, Mitchell MA: Evaluation of cobalamin status in dogs with hepatic disease [abstract]. J Vet Intern Med 2013, 27:716.
• [23]Carmel R: Extreme elevation of serum transcobalamin I in patients with metastatic cancer. N Engl J Med 1975, 292:282-284.
• [24]Boisson F, Fremont S, Migeon C, Nodari F, Droesch S, Gerard P, Parache RM, Nicolas JP: Human haptocorrin in hepatocellular carcinoma. Cancer Detect Prev 1999, 23:89-96.
• [25]Frémont S, Champigneulle B, Gérard P, Felden F, Lambert D, Guéant JL, Nicolas JP: Blood transcobalamin levels in malignant hepatoma. Tumour Biol 1991, 12:353-359.
• [26]Jeffery J, Millar H, Mackenzie P, Fahie-Wilson M, Hamilton M, Ayling RM: An IgG complexed form of vitamin B12 is a common cause of elevated serum concentrations. Clin Biochem 2010, 43:82-88.
• [27]Zittoun J, Zittoun R, Marquet J, Sultan C: The three transcobalamins in myeloproliferative disorders and acute leukaemia. Br J Haematol 1975, 31:287-298.
• [28]Reed N, Gunn-Moore D, Simpson K: Cobalamin, folate and inorganic phosphate abnormalities in ill cats. J Feline Med Surg 2007, 9:278-288.
• [29]Center SA: Feline hepatic lipidosis. Vet Clin North Am Small Anim Pract 2005, 35:225-269.
• [30]Worhunsky P, Toulza O, Rishniw M, Berghoff N, Ruaux CG, Steiner JM, Simpson KW: The relationship of serum cobalamin to methylmalonic acid concentrations and clinical variables in cats. J Vet Intern Med 2013, 27:1056-1063.
• [31]Galler A, Tran JL, Krammer-Lukas S, Höller U, Thalhammer JG, Zentek J, Willmann M: Blood vitamin levels in dogs with chronic kidney disease. Vet J 2012, 192:226-231.
• [32]Altman DH: Clinical Trials. In Practical Statistics in Medical Research. Chapman and Hall, London; 1991:440-476.
• [33]Kook PH, Lutz S, Sewell AC, Bigler B, Reusch CE: Evaluation of serum cobalamin concentration in cats with clinical signs of gastrointestinal disease. Schweiz Arch Tierheilkd 2012, 154:479-486.
• [34]Barron PM, Mackie JT, Evans NA, Langer N: Serum cobalamin concentrations in healthy cats and cats with non-alimentary tract illness in Australia. Aust Vet J 2009, 87:280-283.
• [35]Ruaux CG, Steiner JM, Williams DA: Relationships between low serum cobalamin concentrations and methlymalonic acidemia in cats. J Vet Intern Med 2009, 23:472-475.